CAM
VNDA icon

Cortina Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Cortina Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-281,742
Closed -$4.75M – 246
2018
Q1 		$4.75M Sell
281,742
-104,735
-27% -$1.75M 0.23% 171
2017
Q4 		$5.87M Buy
386,477
+173,974
+82% +$2.58M 0.26% 149
2017
Q3 		$3.8M Buy
212,503
+171,918
+424% +$2.88M 0.16% 200
2017
Q2 		$662K Buy
+40,585
New +$585K 0.03% 218

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cortina Asset Management's VNDA Position: Q2 2018 in Review

Cortina Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2018, closing a stake of 281,742 shares — an estimated $4.75M sold.

Cortina Asset Management first reported a position in VNDA in Q2 2017 and held it in 4 quarters. The position peaked at $5.87M in Q4 2017. 135 funds tracked by Wall St. Rank hold VNDA as of Q2 2018.

  • Cortina Asset Management reported no remaining Vanda Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Cortina Asset Management sold 281,742 Vanda Pharmaceuticals shares in Q2 2018, an estimated $4.75M.
  • Cortina Asset Management first reported a position in Vanda Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Cortina Asset Management's Vanda Pharmaceuticals position peaked at $5.87M in Q4 2017.
  • 135 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2018.

Based on Cortina Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.